Navigation Links
DILON Diagnostics And GE Healthcare Announce Exclusive North America Distribution Agreement For The Discovery NM750b Molecular Breast Imaging System
Date:11/15/2016

NEWPORT NEWS, Va., Nov. 15, 2016 /PRNewswire/ -- DILON Diagnostics and GE Healthcare are pleased to announce that they have signed an agreement for DILON to be the exclusive distributor of GE's Discovery NM750b Molecular Breast Imaging system in North America.  The signing of this exclusive agreement brings closer together two significant players in Molecular Breast Imaging. Last year, GE Healthcare and DILON Diagnostics signed a global distribution agreement in select world markets.

The Discovery NM750b breast imaging system offers clinicians an important tool for imaging of a broad range of patients, including those with dense breasts who may be at higher risk for breast cancer. The power of functional imaging to see early changes is a key factor in early detection in breast cancer.

"We are very pleased to continue collaborating with GE Healthcare, a world leader in innovation, in the fight against breast cancer. The relationship with GE Healthcare will enable us to offer a complete spectrum of BSGI/MBI solutions through our established sales channels in breast cancer diagnostics and surgery," says Robert G. Moussa, DILON Diagnostics Chairman and CEO. Nathan Hermony, Nuclear Imaging global business manager for GE Healthcare, added that "GE believes strongly in this advanced technology and the potential for this type of imaging to improve breast cancer diagnosis. DILON Diagnostics will further the education and acceptance of Molecular Breast Imaging."

About DILON Diagnostics
DILON Diagnostics, a brand of DILON Technologies, Inc., located in Newport News, Virginia, designs, manufactures and commercializes innovative medical imaging solutions worldwide.  DILON's cornerstone product, the DILON Molecular Imaging System, is a high-resolution, compact camera for imaging small body parts, such as the breast, thyroid, parathyroid and bone. The DILON Molecular Imaging System has been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. For more information on DILON Diagnostics please visit www.dilon.com

About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information visit our website www.gehealthcare.com

Media contact: Pjerin Luli
P: 757-269-4910
E: pluli@dilon.com

Logo - http://photos.prnewswire.com/prnh/20140106/PH40697LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dilon-diagnostics-and-ge-healthcare-announce-exclusive-north-america-distribution-agreement-for-the-discovery-nm750b-molecular-breast-imaging-system-300363683.html


'/>"/>
SOURCE Dilon Technologies, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. DILON Diagnostics and GE Healthcare will present GE Healthcares FDA 510k pending dual head MBI localization accessory for breast biopsy* at the SBI/ACR Breast Imaging Symposium in April 7-9
2. DILON Diagnostics and GE Healthcare announce a global distribution agreement for the Discovery NM750b Molecular Breast Imaging system
3. Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem
4. Digirad Signs Exclusive International Distribution Agreement with Dilon Diagnostics
5. Global Companion Diagnostics Market Analysis & Trends Report 2016-2025 - Growth Opportunities/Investment Opportunities - Research and Markets
6. Amarantus Completes Sale of Diagnostics Division, Announces Fiscal Year 2015 and First Quarter 2016 Financial Results
7. Point of Care Molecular Diagnostics Market Worth $3.9 Billion by 2024: Grand View Research, Inc.
8. Granger Diagnostics Introduces Wound~Seq, a Next-Generation Care Test for Diabetic Wounds
9. Global In-Vitro Diagnostics (IVD) Market 2012 to 2022 - Research and Markets
10. Global Pharma, Biotech & Diagnostics Co-promotion and Co-marketing Partnering Terms and Agreements Analysis 2010-2016 - Research and Markets
11. Transplant Diagnostics Market Worth 753.9 Million USD by 2021
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2019)... ... 14, 2019 , ... Life Molecular Imaging (LMI) and Chulabhorn ... a research collaboration to investigate the accumulation of beta-amyloid plaques and neurofibrillary Tau ... recruited and imaged. LMI and Chulabhorn Royal Academy leveraged their joint resources to ...
(Date:6/13/2019)... Colo. (PRWEB) , ... June 13, 2019 , ... ... thrilled to open its doors to a wellness center dedicated to realizing your ... of Atagi Plastic Surgery & Skin Aesthetics, BESANA Health & Wellness offers a ...
(Date:6/13/2019)... SHORE, N.Y. (PRWEB) , ... June 13, 2019 ... ... IP audio/video recording, IoT sensor technology and passive visual weapons detection systems, is ... Sensor and Milestone XProtect®. As a verified technology partner IPVideo’s award-winning ...
Breaking Medicine Technology:
(Date:6/13/2019)... ... ... In Partnership with the Smiles for Everyone Foundation , Monarch ... TX office on July 13th. , Dental services provided include same-day procedures such as ... more information, please visit the Monarch Dental website . , About Monarch Dental® ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... In two ... schools across the United States, the collective impact movement Active Schools aimed ... are not, promoting childhood health and well-being. , The U.S. Department of Health ...
(Date:6/13/2019)... , ... June 13, 2019 , ... ... has announced that the final entry deadline in the 2019 competition is extended ... Recognized as the world’s premier business awards program, The IBAs attract nominations from ...
(Date:6/13/2019)... NEW YORK (PRWEB) , ... June 13, 2019 ... ... Values in Patients Taking SGLT-2 Inhibitors” presented at the American Diabetes Association (ADA) ... 2 diabetes that are being treated with an SGLT-2 inhibitor. SGLT-2 inhibitors are ...
(Date:6/12/2019)... (PRWEB) , ... June 12, 2019 , ... ... cannabis product label experts, get valuable advice on innovative branding and network with ... marketing? Business owners, scientists, media representatives, farmers, nutritionists, manufacturers and others who are ...
Breaking Medicine News(10 mins):